Suppr超能文献

伴有和不伴有肿瘤同期切除的散发性内耳神经鞘瘤患者的人工耳蜗植入效果。

Cochlear Implantation Outcomes in Patients With Sporadic Inner Ear Schwannomas With and Without Simultaneous Tumor Resection.

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of Colorado Anschutz School of Medicine, Aurora, Colorado.

Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota.

出版信息

Otol Neurotol. 2024 Oct 1;45(9):1051-1054. doi: 10.1097/MAO.0000000000004268. Epub 2024 Aug 5.

Abstract

OBJECTIVES

Describe a single institution's cochlear implant outcomes for patients with inner ear schwannomas (IES) in the setting of various tumor management strategies (observation, surgical resection, or stereotactic radiosurgery [SRS]).

STUDY DESIGN

Single-institution retrospective review.

PATIENTS

Patients diagnosed with isolated, sporadic IES who underwent cochlear implantation (CI).

INTERVENTIONS

CI with or without IES treatment.

MAIN OUTCOME MEASURES

Speech perception outcomes, tumor status.

RESULTS

Twelve patients with IES underwent CI with a median audiologic and radiologic follow-up of 12 months. Six patients underwent complete resection of the tumor at the time of CI, four underwent tumor observation, and two underwent SRS before CI. At 1 year after CI for all patients, the median consonant-nucleus-consonant (CNC) word score was 55% (interquartile range, 44-73%), and the median AzBio sentence in quiet score was 77% (interquartile range, 68-93%). Overall, those with surgical resection performed similarly to those with tumor observation (CNC 58 versus 61%; AzBio in quiet 74 versus 91%, respectively). Patients who underwent tumor resection before implantation had a wider range of speech performance outcomes compared with patients who underwent tumor observation. Two patients had SRS treatment before CI (10 months previous and same-day as CI) with CNC word scores of 6 and 40%, respectively.

CONCLUSIONS

Patients with IES who underwent CI demonstrated similar speech performance outcomes (CNC 56% and AzBio 82%), when compared with the general cochlear implant population. Patients who underwent either tumor observation or surgical resection performed well after CI.

摘要

目的

描述在不同肿瘤管理策略(观察、手术切除或立体定向放射外科手术[SRS])背景下,单一机构的内耳神经鞘瘤(IES)患者的耳蜗植入(CI)结果。

研究设计

单机构回顾性研究。

患者

被诊断为孤立性、散发性 IES 并接受 CI 的患者。

干预措施

有或没有 IES 治疗的 CI。

主要观察指标

言语感知结果,肿瘤状态。

结果

12 例 IES 患者接受了 CI,平均听力和影像学随访时间为 12 个月。6 例患者在 CI 时行肿瘤完全切除术,4 例患者行肿瘤观察,2 例患者在 CI 前行 SRS。所有患者在 CI 后 1 年,中值辅音-核-辅音(CNC)单词得分 55%(四分位间距,44%-73%),中值 AzBio 安静句子得分 77%(四分位间距,68%-93%)。总体而言,接受手术切除的患者与接受肿瘤观察的患者表现相似(CNC 分别为 58%和 61%;AzBio 分别为 74%和 91%)。与接受肿瘤观察的患者相比,在植入前接受肿瘤切除术的患者的言语表现结果范围更广。2 例患者在 CI 前(10 个月前和 CI 当天)接受 SRS 治疗,CNC 单词得分分别为 6%和 40%。

结论

与一般的耳蜗植入人群相比,接受 CI 的 IES 患者具有相似的言语表现结果(CNC 为 56%,AzBio 为 82%)。接受肿瘤观察或手术切除的患者在 CI 后表现良好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验